Reactivity of pyruvic acid and its derivatives towards reactive oxygen species
| Autor: | Teresa Piechowska, Mariola Marchlewicz, Aleksandra Kładna, Hassan Y. Aboul-Enein, Irena Kruk |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
chemistry.chemical_classification
Reactive oxygen species Antioxidant Superoxide Radical medicine.medical_treatment Biophysics Free radical scavenger Medicinal chemistry chemistry.chemical_compound Sodium pyruvate chemistry Deoxyribose Chemistry (miscellaneous) medicine Organic chemistry Pyruvic acid |
| Zdroj: | Luminescence. 30:1153-1158 |
| ISSN: | 1522-7235 |
| DOI: | 10.1002/bio.2879 |
| Popis: | Pyruvic acid and its derivatives occurring in most biological systems are known to exhibit several pharmacological properties, such as anti-inflammatory, neuroprotective or anticancer, many of which are suggested to originate from their antioxidant and free radical scavenger activity. The therapeutic potential of these compounds is a matter of particular interest, due to their mechanisms of action, particularly their possible antioxidant behaviour. Here, we report the results of a study of the effect of pyruvic acid (PA), ethyl pyruvate (EP) and sodium pyruvate (SP) on reactions generating reactive oxygen species (ROS), such as superoxide anion radicals, hydroxyl radicals and singlet oxygen, and their total antioxidant capacity. Chemiluminescence (CL) and spectrophotometry techniques were employed. The pyruvate analogues studied were found to inhibit the CL signal arising from superoxide anion radicals in a dose-dependent manner with IC50 = 0.0197 ± 0.002 mM for EP and IC50 = 69.2 ± 5.2 mM for PA. These compounds exhibited a dose-dependent decrease in the CL signal of the luminol + H2O2 system over the range 0.5-10 mM with IC50 values of 1.71 ± 0.12 mM for PA, 3.85 ± 0.21 mM for EP and 22.91 ± 1.21 mM for SP. Furthermore, these compounds also inhibited hydroxyl radical-dependent deoxyribose degradation in a dose-dependent manner over the range 0.5-200 mM, with IC50 values of 33.2 ± 0.3 mM for SP, 116.1 ± 6.2 mM for EP and 168.2 ± 6.2 mM for PA. All the examined compounds also showed antioxidant capacity when estimated using the ferric-ferrozine assay. The results suggest that the antioxidant activities of pyruvate derivatives may reflect a direct effect on scavenging ROS and, in part, be responsible for their pharmacological actions. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text